{
  "url": "https://finance.yahoo.com/news/european-growth-stocks-insiders-confident-054032327.html?.tsrc=rss",
  "authorsByline": "Simply Wall St",
  "articleId": "0babcf3ce8fe408fa211fb70bf99ed0a",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/simply_wall_st__316/de08ce5a09ed74f962345d43f617cd22",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-25T05:40:32+00:00",
  "addDate": "2025-08-25T06:22:11.029449+00:00",
  "refreshDate": "2025-08-25T06:22:11.029451+00:00",
  "score": 1.0,
  "title": "European Growth Stocks Insiders Are Confident In",
  "description": "As European markets experience a boost from the prospect of lower U.S. borrowing costs, with indices like the STOXX Europe 600 Index rising, investors are increasingly focused on growth opportunities within the region. In this context, companies that combine robust growth potential with high insider ownership can be particularly appealing, as they often indicate strong internal confidence and alignment with shareholder interests.",
  "content": "As European markets experience a boost from the prospect of lower U.S. borrowing costs, with indices like the STOXX Europe 600 Index rising, investors are increasingly focused on growth opportunities within the region. In this context, companies that combine robust growth potential with high insider ownership can be particularly appealing, as they often indicate strong internal confidence and alignment with shareholder interests.\n\nClick here to see the full list of 219 stocks from our Fast Growing European Companies With High Insider Ownership screener.\n\nBelow we spotlight a couple of our favorites from our exclusive screener.\n\nOverview: PostNL N.V. offers postal and logistics services to businesses and consumers in the Netherlands, Europe, and internationally, with a market cap of \u20ac509.70 million.\n\nOperations: The company generates revenue from its Parcels segment, amounting to \u20ac2.41 billion, and Mail in The Netherlands segment, contributing \u20ac1.32 billion.\n\nPostNL is trading significantly below its estimated fair value, which suggests potential undervaluation. Despite a highly volatile share price recently, the company is expected to become profitable within three years, with earnings forecasted to grow 65% annually. However, revenue growth at 2.1% per year lags behind the Dutch market average of 7.1%, and interest payments are not well covered by earnings. Recent half-year results showed increased sales but a net loss of \u20ac41 million compared to last year.\n\u2022 Navigate through the intricacies of PostNL with our comprehensive analyst estimates report here.\n\u2022 Insights from our recent valuation report point to the potential undervaluation of PostNL shares in the market.\n\nOverview: Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training globally, with a market cap of SEK5.39 billion.\n\nOperations: Surgical Science Sweden AB (publ) generates revenue through the development and marketing of virtual reality simulators designed for evidence-based medical training across Europe, the Americas, Asia, and other international markets.",
  "medium": "Article",
  "links": [
    "https://simplywall.st/company/id/0ba35394-2e5c-478c-b824-85c66b0ca2d5/ownership?utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo&amp;blueprint=4014249",
    "https://simplywall.st/company/id/0ba35394-2e5c-478c-b824-85c66b0ca2d5?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=4014249",
    "https://simplywall.st/company/id/0ba35394-2e5c-478c-b824-85c66b0ca2d5/future?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014249",
    "https://simplywall.st/company/id/6d462f81-37d0-4d3f-a579-da51729a1cef?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=4014249",
    "https://simplywall.st/discover/investing-ideas/10228/fast-growing-stocks-with-high-insider-ownership/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=4014249",
    "https://simplywall.st/company/id/0ba35394-2e5c-478c-b824-85c66b0ca2d5/valuation?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014249"
  ],
  "labels": [],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "European markets",
      "weight": 0.08687488
    },
    {
      "name": "revenue growth",
      "weight": 0.08590244
    },
    {
      "name": "High Insider Ownership",
      "weight": 0.08449111
    },
    {
      "name": "high insider ownership",
      "weight": 0.08449111
    },
    {
      "name": "other international markets",
      "weight": 0.07882468
    },
    {
      "name": "robust growth potential",
      "weight": 0.07836446
    },
    {
      "name": "PostNL shares",
      "weight": 0.07769163
    },
    {
      "name": "virtual reality simulators",
      "weight": 0.07559715
    },
    {
      "name": "last year",
      "weight": 0.07550757
    },
    {
      "name": "growth opportunities",
      "weight": 0.07364092
    }
  ],
  "topics": [
    {
      "name": "Markets"
    }
  ],
  "categories": [
    {
      "name": "Finance"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.98291015625
    },
    {
      "name": "/Finance/Investing/Stocks & Bonds",
      "score": 0.98193359375
    },
    {
      "name": "/News/Business News/Company News",
      "score": 0.97802734375
    }
  ],
  "sentiment": {
    "positive": 0.2558153,
    "negative": 0.22216125,
    "neutral": 0.52202344
  },
  "summary": "As European markets rise due to the prospect of lower U.S. borrowing costs, investors are increasingly focusing on growth opportunities within the region. PostNL N.V. offers postal and logistics services in the Netherlands, Europe, and internationally, with a market cap of \u20ac509.70 million. Despite a volatile share price, PostNL is expected to become profitable within three years and its earnings are forecasted to grow 65% annually. However, revenue growth at 2.1% per year lags behind the Dutch market average of 7.1%, and interest payments are not well covered by earnings.",
  "shortSummary": "As European markets experience a boost with lower borrowing costs, high insider ownership, and potential undervaluation, we spotlight some promising growth prospects.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": true,
  "reprintGroupId": "d4d6877ad01844c1a5f8d005ae8cbfbc",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://simplywall.st/discover/investing-ideas/10228/fast-growing-stocks-with-high-insider-ownership/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=4014249",
      "text": "Results\n1374\nCompanies with strong growth potential, backed by optimistic outlooks both from analysts and management.\n1374 companies\nGold Circuit Electronics\nMarket Cap: NT$223.4b\nDesigns, manufactures, processes, and distributes printed circuit boards in Taiwan.\n2368\nNT$459.00\n7D\n-1.4%\n1Y\n112.5%\nFulin Precision\nMarket Cap: CN\u00a526.5b\nEngages in the research and development, manufacture, and sale of automotive engine parts in China.\n300432\nCN\u00a515.51\n7D\n-1.1%\n1Y\n235.6%\nSynspective\nMarket Cap: JP\u00a594.5b\nDesigns, builds, and operates a fleet of synthetic aperture radar satellites (SAR) to detect and understand changes.\n290A\nJP\u00a5847.00\n7D\n-12.8%\n1Y\nn/a\nNovoray\nMarket Cap: CN\u00a514.6b\nProvides industrial powder materials for various applications in China and internationally.\n688300\nCN\u00a560.54\n7D\n3.6%\n1Y\n92.9%\nLaopu Gold\nMarket Cap: HK$125.8b\nDesigns, manufactures, and sells jewelry products in Mainland China, Hong Kong, and Macau.\n6181\nHK$728.50\n7D\n-6.6%\n1Y\n686.7%\nAscentage Pharma Group International\nMarket Cap: HK$33.7b\nA clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.\n6855\nHK$90.65\n7D\n5.3%\n1Y\n215.9%\nCyclopharm\nMarket Cap: AU$108.9m\nCyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.\nCYC\nAU$0.98\n7D\n-5.8%\n1Y\n-30.2%\nFindi\nMarket Cap: AU$239.2m\nThrough its subsidiaries, engages in the development of digital payment systems in India.\nFND\nAU$3.87\n7D\n-3.5%\n1Y\n-5.1%\nElliptic Laboratories\nMarket Cap: NOK 1.2b\nAn artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive markets in Norway, the United States, China, South Korea, Taiwan, and Japan.\nELABS\nNOK 11.06\n7D\n-7.8%\n1Y\n-10.7%\nPharma Mar\nMarket Cap: \u20ac1.4b\nA biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.\nPHM\n\u20ac82.45\n7D\n-2.5%\n1Y\n101.7%\nCD Projekt\nMarket Cap: z\u014225.8b\nTogether its subsidiaries, engages in the development, publishing, and digital distribution of video games for personal computers and video game consoles in Poland.\nCDR\nz\u0142257.90\n7D\n1.1%\n1Y\n43.1%\nKebNi\nMarket Cap: SEK 688.7m\nDevelops, produces, and sells products and applications for stabilization, navigation, and satcom worldwide.\nKEBNI B\nSEK 2.54\n7D\n17.1%\n1Y\n76.6%\nCredo Technology Group Holding\nMarket Cap: US$19.6b\nProvides various high-speed connectivity solutions for optical and electrical Ethernet, and PCIe applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally.\nCRDO\nUS$114.04\n7D\n-4.0%\n1Y\n223.9%\nPropel Holdings\nMarket Cap: CA$1.3b\nOperates as a financial technology company.\nPRL\nCA$32.76\n7D\n-0.06%\n1Y\n17.4%\nHesai Group\nMarket Cap: US$3.1b\nThrough with its subsidiaries, engages in the development, manufacture, and sale of three-dimensional light detection and ranging solutions (LiDAR) in Mainland China, Europe, North America, and internationally.\nHSAI\nUS$23.26\n7D\n-9.1%\n1Y\n445.4%\nNewfield Resources\nMarket Cap: AU$83.7m\nEngages in the mine development, stope mining, and mineral exploration activities in Australia and Africa.\nNWF\nAU$0.089\n7D\n0%\n1Y\n-19.1%\nSuzhou Sunmun Technology\nMarket Cap: CN\u00a54.6b\nEngages in the research, production, and sale of nano-coloring materials, functional nano-dispersions, special additives, intelligent color matching systems, and electronic chemicals in China.\n300522\nCN\u00a514.24\n7D\n-0.8%\n1Y\n54.4%\nAprilBioLtd\nMarket Cap: \u20a9474.2b\nAprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.\nA397030\n\u20a921,050.00\n7D\n-2.3%\n1Y\n1.7%\nM31 Technology\nMarket Cap: NT$19.7b\nProvides silicon intellectual property (IP) design services in the integrated circuit industry.\n6643\nNT$472.50\n7D\n-5.9%\n1Y\n-53.2%\nImage Resources\nMarket Cap: AU$88.1m\nEngages in the production and exploration of mineral sands in Western Australia.\nIMA\nAU$0.079\n7D\n0%\n1Y\n8.2%\nVuno\nMarket Cap: \u20a9291.9b\nOperates as a medical artificial intelligence (AI) solution development company.\nA338220\n\u20a920,850.00\n7D\n4.0%\n1Y\n-44.4%\nAnand Rathi Wealth\nMarket Cap: \u20b9233.0b\nProvides financial advisory, brokerage, and consultancy services in India.\nANANDRATHI\n\u20b92,806.20\n7D\n3.5%\n1Y\n55.7%\nTechwing\nMarket Cap: \u20a91.0t\nDevelops, manufactures, sells, and services semiconductor inspection equipment in South Korea and internationally.\nA089030\n\u20a928,850.00\n7D\n-1.2%\n1Y\n-37.1%\nBinastra Corporation Berhad\nMarket Cap: RM 1.9b\nAn investment holding company, engages in general contractor and property developer, building and civil engineering works in turnkey projects in Malaysia.\nBNASTRA\nRM 1.78\n7D\n0.6%\n1Y\n44.7%\nSineng ElectricLtd\nMarket Cap: CN\u00a512.3b\nEngages in the research and development, manufacture, maintenance, and trading of power electronic products in the People's Republic of China and internationally.\n300827\nCN\u00a524.59\n7D\n-0.04%\n1Y\n12.2%\nSamyang Foods\nMarket Cap: \u20a910.7t\nEngages in the food business in South Korea and internationally.\nA003230\n\u20a91,438,000.00\n7D\n4.2%\n1Y\n187.6%\nZhejiang Leapmotor Technology\nMarket Cap: HK$99.9b\nEngages in the research and development, production, and sale of new energy vehicles in Mainland China and internationally.\n9863\nHK$71.00\n7D\n8.6%\n1Y\n249.8%\nFenix Resources\nMarket Cap: AU$227.0m\nEngages in the exploration, development, and mining of mineral tenements in Western Australia.\nFEX\nAU$0.30\n7D\n-7.6%\n1Y\n0%\nOscotec\nMarket Cap: \u20a91.2t\nOperates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.\nA039200\n\u20a932,600.00\n7D\n-5.5%\n1Y\n-18.4%\nKrishna Institute of Medical Sciences\nMarket Cap: \u20b9294.8b\nProvides medical and health care services under the KIMS Hospitals brand in India.\nKIMS\n\u20b9736.80\n7D\n-1.1%\n1Y\n49.1%\nMarinomed Biotech\nMarket Cap: \u20ac35.2m\nA biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.\nMARI\n\u20ac19.80\n7D\n1.0%\n1Y\n253.6%\nHippo Holdings\nMarket Cap: US$844.7m\nProvides property and casualty insurance products to individuals and business customers primarily in the United States.\nHIPO\nUS$33.75\n7D\n6.7%\n1Y\n70.0%\nBergen Carbon Solutions\nMarket Cap: NOK 187.6m\nOperates as a clean carbon technology and materials company in Norway.\nBCS\nNOK 4.47\n7D\n-6.7%\n1Y\n-12.4%\nENGAGE XR Holdings\nMarket Cap: UK\u00a35.4m\nEngages in the development of the educational virtual reality platform.\nEXR\nUK\u00a30.01\n7D\n0%\n1Y\n17.1%\nAtour Lifestyle Holdings\nMarket Cap: US$4.9b\nThrough its subsidiaries, develops lifestyle brands around hotel offerings in the People\u2019s Republic of China.\nATAT\nUS$35.73\n7D\n2.4%\n1Y\n103.9%\nCircus\nMarket Cap: \u20ac402.0m\nA technology company, develops and delivers autonomous solutions for the food service market.\nCA1\n\u20ac16.90\n7D\n-12.7%\n1Y\n-21.8%"
    },
    {
      "url": "https://simplywall.st/company/id/6d462f81-37d0-4d3f-a579-da51729a1cef?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=4014249",
      "text": "Surgical Science Sweden (SUS) Stock Overview\nDevelops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 4/6 |\n| Future Growth | 4/6 |\n| Past Performance | 2/6 |\n| Financial Health | 5/6 |\n| Dividends | 0/6 |\nRewards\nRisk Analysis\nSUS Community Fair Values\nSee what 16 others think this stock is worth. Follow their fair value or set your own to get alerts.\nSurgical Science Sweden AB (publ) Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | SEK 105.70 |\n| 52 Week High | SEK 192.40 |\n| 52 Week Low | SEK 96.80 |\n| Beta | 0.64 |\n| 1 Month Change | -33.02% |\n| 3 Month Change | -26.60% |\n| 1 Year Change | -18.38% |\n| 3 Year Change | -36.25% |\n| 5 Year Change | 31.47% |\n| Change since IPO | 819.13% |\nRecent News & Updates\nEarnings Miss: Surgical Science Sweden AB (publ) Missed EPS And Analysts Are Revising Their Forecasts\nAug 24What You Can Learn From Surgical Science Sweden AB (publ)'s (STO:SUS) P/E After Its 32% Share Price Crash\nAug 20Recent updates\nEarnings Miss: Surgical Science Sweden AB (publ) Missed EPS And Analysts Are Revising Their Forecasts\nAug 24What You Can Learn From Surgical Science Sweden AB (publ)'s (STO:SUS) P/E After Its 32% Share Price Crash\nAug 20The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS) Even After Diving 27%\nMar 14Surgical Science Sweden's (STO:SUS) Sluggish Earnings Might Be Just The Beginning Of Its Problems\nMar 01Regulatory Approvals For New Robotics Entrants Will Drive Demand For Simulation Products\nStrength in the Educational Products segment and rising demand for simulators indicate potential revenue growth and diversification opportunities.The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)\nNov 12Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next\nAug 25Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models\nApr 21Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors\nApr 16Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump\nMar 17Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts\nFeb 24Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?\nNov 29Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?\nOct 07Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?\nAug 17With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case\nJun 20A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)\nMay 17Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate\nDec 27Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?\nDec 06Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?\nSep 08We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease\nAug 23Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless\nMay 26Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching\nApr 29An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued\nFeb 20Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?\nJan 11Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?\nDec 15Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)\nSep 16Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?\nJul 05Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)\nJun 08Shareholder Returns\n| SUS | SE Medical Equipment | SE Market | |\n|---|---|---|---|\n| 7D | 7.4% | 2.7% | 2.2% |\n| 1Y | -18.4% | -14.9% | 0.6% |\nReturn vs Industry: SUS underperformed the Swedish Medical Equipment industry which returned -14.9% over the past year.\nReturn vs Market: SUS underperformed the Swedish Market which returned 0.6% over the past year.\nPrice Volatility\n| SUS volatility | |\n|---|---|\n| SUS Average Weekly Movement | 9.0% |\n| Medical Equipment Industry Average Movement | 8.6% |\n| Market Average Movement | 5.7% |\n| 10% most volatile stocks in SE Market | 12.8% |\n| 10% least volatile stocks in SE Market | 3.1% |\nStable Share Price: SUS's share price has been volatile over the past 3 months compared to the Swedish market.\nVolatility Over Time: SUS's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1997 | 327 | Tom Englund | www.surgicalscience.com |\nSurgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room.\nSurgical Science Sweden AB (publ) Fundamentals Summary\n| SUS fundamental statistics | |\n|---|---|\n| Market cap | SEK 5.39b |\n| Earnings (TTM) | SEK 92.45m |\n| Revenue (TTM) | SEK 943.23m |\nIs SUS overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| SUS income statement (TTM) | |\n|---|---|\n| Revenue | SEK 943.23m |\n| Cost of Revenue | SEK 303.15m |\n| Gross Profit | SEK 640.08m |\n| Other Expenses | SEK 547.64m |\n| Earnings | SEK 92.45m |\nLast Reported Earnings\nJun 30, 2025\nNext Earnings Date\nNov 13, 2025\n| Earnings per share (EPS) | 1.81 |\n| Gross Margin | 67.86% |\n| Net Profit Margin | 9.80% |\n| Debt/Equity Ratio | 0.04% |\nHow did SUS perform over the long term?\nSee historical performance and comparisonCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/24 23:03 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nSurgical Science Sweden AB (publ) is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Simon Jonsson | Berenberg |\n| Viktor H\u00f6gberg | Danske Bank |\n| Jonatan Andersson | DNB Carnegie |"
    },
    {
      "url": "https://simplywall.st/company/id/0ba35394-2e5c-478c-b824-85c66b0ca2d5/future?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014249",
      "text": "PostNL Future Growth\nFuture criteria checks 4/6\nPostNL is forecast to grow earnings and revenue by 65% and 2.1% per annum respectively. EPS is expected to grow by 63.8% per annum. Return on equity is forecast to be 20.9% in 3 years.\nKey information\n65.0%\nEarnings growth rate\n63.81%\nEPS growth rate\n| Logistics earnings growth | 14.8% |\n| Revenue growth rate | 2.1% |\n| Future return on equity | 20.90% |\n| Analyst coverage | Low |\n| Last updated | 04 Aug 2025 |\nRecent future growth updates\nRecent updates\nIs PostNL (AMS:PNL) Using Too Much Debt?\nJul 25Market Participants Recognise PostNL N.V.'s (AMS:PNL) Earnings\nMay 07We Think PostNL N.V.'s (AMS:PNL) CEO Compensation Package Needs To Be Put Under A Microscope\nApr 08Some Investors May Be Willing To Look Past PostNL's (AMS:PNL) Soft Earnings\nMar 03International Expansion And Parcel Lockers Will Strengthen Future E-Commerce Operations\nStrategic expansion in e-commerce and parcel lockers supports revenue growth, leveraging strong free cash flow for dividends and investor confidence.PostNL N.V. (AMS:PNL) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates\nNov 07PostNL's (AMS:PNL) Earnings Offer More Than Meets The Eye\nAug 12We Think Shareholders May Want To Consider A Review Of PostNL N.V.'s (AMS:PNL) CEO Compensation Package\nApr 10Is PostNL (AMS:PNL) A Risky Investment?\nFeb 17Estimating The Intrinsic Value Of PostNL N.V. (AMS:PNL)\nSep 23Is PostNL (AMS:PNL) Using Debt Sensibly?\nSep 02Why PostNL N.V. (AMS:PNL) Could Be Worth Watching\nJul 13PostNL N.V. (AMS:PNL) Shares Could Be 41% Below Their Intrinsic Value Estimate\nJun 16These 4 Measures Indicate That PostNL (AMS:PNL) Is Using Debt Extensively\nJan 26Is It Time To Consider Buying PostNL N.V. (AMS:PNL)?\nNov 09Is PostNL (AMS:PNL) A Risky Investment?\nOct 23A Look At The Fair Value Of PostNL N.V. (AMS:PNL)\nSep 07Should You Think About Buying PostNL N.V. (AMS:PNL) Now?\nAug 04Does PostNL (AMS:PNL) Have A Healthy Balance Sheet?\nJul 20An Intrinsic Calculation For PostNL N.V. (AMS:PNL) Suggests It's 29% Undervalued\nMay 26When Should You Buy PostNL N.V. (AMS:PNL)?\nApr 21Is PostNL (AMS:PNL) A Risky Investment?\nApr 01At \u20ac3.45, Is It Time To Put PostNL N.V. (AMS:PNL) On Your Watch List?\nJan 20Is PostNL (AMS:PNL) A Risky Investment?\nDec 14Is Now The Time To Look At Buying PostNL N.V. (AMS:PNL)?\nOct 11PostNL (AMS:PNL) Seems To Use Debt Quite Sensibly\nAug 01When Should You Buy PostNL N.V. (AMS:PNL)?\nJun 22With EPS Growth And More, PostNL (AMS:PNL) Is Interesting\nMay 25An Intrinsic Calculation For PostNL N.V. (AMS:PNL) Suggests It's 44% Undervalued\nMay 06Earnings and Revenue Growth Forecasts\n| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |\n|---|---|---|---|---|---|\n| 12/31/2027 | 3,457 | 49 | 29 | 264 | 1 |\n| 12/31/2026 | 3,360 | 51 | 41 | 223 | 2 |\n| 12/31/2025 | 3,285 | 35 | 11 | 180 | 2 |\n| 6/28/2025 | 3,280 | -16 | 16 | 114 | N/A |\n| 3/29/2025 | 3,269 | 21 | 56 | 154 | N/A |\n| 12/31/2024 | 3,252 | 18 | 69 | 169 | N/A |\n| 9/28/2024 | 3,205 | 18 | 99 | 208 | N/A |\n| 6/29/2024 | 3,171 | 30 | 142 | 253 | N/A |\n| 3/30/2024 | 3,147 | 31 | 123 | 237 | N/A |\n| 12/31/2023 | 3,165 | 54 | 80 | 206 | N/A |\n| 9/30/2023 | 3,160 | -974 | 32 | 160 | N/A |\n| 7/1/2023 | 3,147 | -985 | 6 | 144 | N/A |\n| 4/1/2023 | 3,122 | -995 | -2 | 139 | N/A |\n| 12/31/2022 | 3,145 | -982 | 101 | 239 | N/A |\n| 10/1/2022 | 3,198 | 59 | 87 | 237 | N/A |\n| 7/2/2022 | 3,218 | 92 | 142 | 298 | N/A |\n| 4/2/2022 | 3,310 | 132 | 232 | 384 | N/A |\n| 12/31/2021 | 3,466 | 228 | 334 | 475 | N/A |\n| 10/2/2021 | 3,552 | 320 | 202 | 333 | N/A |\n| 7/3/2021 | 3,565 | 334 | 189 | 295 | N/A |\n| 4/3/2021 | 3,516 | 326 | 233 | 326 | N/A |\n| 12/31/2020 | 3,255 | 213 | 89 | 166 | N/A |\n| 9/26/2020 | 3,075 | 75 | 225 | 290 | N/A |\n| 6/27/2020 | 2,969 | 65 | 262 | 323 | N/A |\n| 3/31/2020 | 2,861 | 52 | 173 | 237 | N/A |\n| 12/31/2019 | 2,844 | 72 | 152 | 218 | N/A |\n| 9/28/2019 | 2,795 | 129 | 80 | 138 | N/A |\n| 6/29/2019 | 2,797 | 135 | -27 | 45 | N/A |\n| 3/31/2019 | 2,782 | 119 | N/A | -33 | N/A |\n| 12/31/2018 | 2,772 | 127 | N/A | -43 | N/A |\n| 9/29/2018 | 2,760 | 123 | N/A | N/A | N/A |\n| 6/30/2018 | 2,752 | 129 | N/A | 36 | N/A |\n| 3/31/2018 | 2,529 | 161 | N/A | 85 | N/A |\n| 12/31/2017 | 2,725 | 179 | N/A | 89 | N/A |\n| 9/30/2017 | 2,898 | 191 | N/A | 154 | N/A |\n| 7/1/2017 | 3,038 | 157 | N/A | 93 | N/A |\n| 4/1/2017 | 3,419 | 281 | N/A | 125 | N/A |\n| 12/31/2016 | 3,413 | 279 | N/A | 110 | N/A |\n| 10/1/2016 | 3,465 | 285 | N/A | 137 | N/A |\n| 7/2/2016 | 3,475 | 313 | N/A | 224 | N/A |\n| 4/2/2016 | 3,475 | 187 | N/A | 159 | N/A |\n| 12/31/2015 | 3,461 | 183 | N/A | 214 | N/A |\n| 9/26/2015 | 3,451 | 208 | N/A | 232 | N/A |\n| 6/27/2015 | 3,463 | 201 | N/A | 132 | N/A |\n| 3/28/2015 | 3,468 | 204 | N/A | 180 | N/A |\n| 12/31/2014 | 3,473 | 223 | N/A | 202 | N/A |\n| 9/27/2014 | 3,642 | 126 | N/A | 78 | N/A |\nAnalyst Future Growth Forecasts\nEarnings vs Savings Rate: PNL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.6%).\nEarnings vs Market: PNL is forecast to become profitable over the next 3 years, which is considered above average market growth.\nHigh Growth Earnings: PNL is expected to become profitable in the next 3 years.\nRevenue vs Market: PNL's revenue (2.1% per year) is forecast to grow slower than the Dutch market (7.1% per year).\nHigh Growth Revenue: PNL's revenue (2.1% per year) is forecast to grow slower than 20% per year.\nEarnings per Share Growth Forecasts\nFuture Return on Equity\nFuture ROE: PNL's Return on Equity is forecast to be high in 3 years time (20.9%)\nDiscover growth companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/24 06:06 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/28 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nPostNL N.V. is covered by 33 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Maarten Bakker | ABN AMRO Bank N.V. |\n| Marco Limite | Barclays |\n| Susanna Invernizzi | Barclays |"
    },
    {
      "url": "https://simplywall.st/company/id/0ba35394-2e5c-478c-b824-85c66b0ca2d5?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=4014249",
      "text": "PostNL (PNL) Stock Overview\nProvides postal and logistics services to businesses and consumers in the Netherlands, rest of Europe, and internationally. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 4/6 |\n| Future Growth | 4/6 |\n| Past Performance | 0/6 |\n| Financial Health | 2/6 |\n| Dividends | 2/6 |\nRewards\nRisk Analysis\nPNL Community Fair Values\nSee what 34 others think this stock is worth. Follow their fair value or set your own to get alerts.\nPostNL N.V. Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | \u20ac1.00 |\n| 52 Week High | \u20ac1.28 |\n| 52 Week Low | \u20ac0.81 |\n| Beta | 0.58 |\n| 1 Month Change | -4.57% |\n| 3 Month Change | 7.34% |\n| 1 Year Change | -19.90% |\n| 3 Year Change | -54.04% |\n| 5 Year Change | -61.01% |\n| Change since IPO | -94.86% |\nRecent News & Updates\nIs PostNL (AMS:PNL) Using Too Much Debt?\nJul 25Market Participants Recognise PostNL N.V.'s (AMS:PNL) Earnings\nMay 07Recent updates\nIs PostNL (AMS:PNL) Using Too Much Debt?\nJul 25Market Participants Recognise PostNL N.V.'s (AMS:PNL) Earnings\nMay 07We Think PostNL N.V.'s (AMS:PNL) CEO Compensation Package Needs To Be Put Under A Microscope\nApr 08Some Investors May Be Willing To Look Past PostNL's (AMS:PNL) Soft Earnings\nMar 03International Expansion And Parcel Lockers Will Strengthen Future E-Commerce Operations\nStrategic expansion in e-commerce and parcel lockers supports revenue growth, leveraging strong free cash flow for dividends and investor confidence.PostNL N.V. (AMS:PNL) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates\nNov 07PostNL's (AMS:PNL) Earnings Offer More Than Meets The Eye\nAug 12We Think Shareholders May Want To Consider A Review Of PostNL N.V.'s (AMS:PNL) CEO Compensation Package\nApr 10Is PostNL (AMS:PNL) A Risky Investment?\nFeb 17Estimating The Intrinsic Value Of PostNL N.V. (AMS:PNL)\nSep 23Is PostNL (AMS:PNL) Using Debt Sensibly?\nSep 02Why PostNL N.V. (AMS:PNL) Could Be Worth Watching\nJul 13PostNL N.V. (AMS:PNL) Shares Could Be 41% Below Their Intrinsic Value Estimate\nJun 16These 4 Measures Indicate That PostNL (AMS:PNL) Is Using Debt Extensively\nJan 26Is It Time To Consider Buying PostNL N.V. (AMS:PNL)?\nNov 09Is PostNL (AMS:PNL) A Risky Investment?\nOct 23A Look At The Fair Value Of PostNL N.V. (AMS:PNL)\nSep 07Should You Think About Buying PostNL N.V. (AMS:PNL) Now?\nAug 04Does PostNL (AMS:PNL) Have A Healthy Balance Sheet?\nJul 20An Intrinsic Calculation For PostNL N.V. (AMS:PNL) Suggests It's 29% Undervalued\nMay 26When Should You Buy PostNL N.V. (AMS:PNL)?\nApr 21Is PostNL (AMS:PNL) A Risky Investment?\nApr 01At \u20ac3.45, Is It Time To Put PostNL N.V. (AMS:PNL) On Your Watch List?\nJan 20Is PostNL (AMS:PNL) A Risky Investment?\nDec 14Is Now The Time To Look At Buying PostNL N.V. (AMS:PNL)?\nOct 11PostNL (AMS:PNL) Seems To Use Debt Quite Sensibly\nAug 01When Should You Buy PostNL N.V. (AMS:PNL)?\nJun 22With EPS Growth And More, PostNL (AMS:PNL) Is Interesting\nMay 25An Intrinsic Calculation For PostNL N.V. (AMS:PNL) Suggests It's 44% Undervalued\nMay 06Shareholder Returns\n| PNL | NL Logistics | NL Market | |\n|---|---|---|---|\n| 7D | 9.6% | -0.9% | 1.3% |\n| 1Y | -19.9% | 7.7% | 0.6% |\nReturn vs Industry: PNL underperformed the Dutch Logistics industry which returned 7.5% over the past year.\nReturn vs Market: PNL underperformed the Dutch Market which returned -0.2% over the past year.\nPrice Volatility\n| PNL volatility | |\n|---|---|\n| PNL Average Weekly Movement | 5.4% |\n| Logistics Industry Average Movement | 3.1% |\n| Market Average Movement | 3.9% |\n| 10% most volatile stocks in NL Market | 7.4% |\n| 10% least volatile stocks in NL Market | 2.1% |\nStable Share Price: PNL's share price has been volatile over the past 3 months compared to the Dutch market.\nVolatility Over Time: PNL's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of Dutch stocks.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| n/a | 32,405 | Pim Berendsen | www.postnl.nl |\nPostNL N.V. provides postal and logistics services to businesses and consumers in the Netherlands, rest of Europe, and internationally. The company operates through Parcels and Mail in the Netherlands and PostNL Other segments. It collects, sorts, transports, and delivers letters and parcels; and offers data management, direct marketing, and fulfillment services, as well as cross-border mail and parcels solutions.\nPostNL N.V. Fundamentals Summary\n| PNL fundamental statistics | |\n|---|---|\n| Market cap | \u20ac509.70m |\n| Earnings (TTM) | -\u20ac16.00m |\n| Revenue (TTM) | \u20ac3.28b |\nIs PNL overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| PNL income statement (TTM) | |\n|---|---|\n| Revenue | \u20ac3.28b |\n| Cost of Revenue | \u20ac2.94b |\n| Gross Profit | \u20ac344.00m |\n| Other Expenses | \u20ac360.00m |\n| Earnings | -\u20ac16.00m |\nLast Reported Earnings\nJun 28, 2025\nNext Earnings Date\nNov 03, 2025\n| Earnings per share (EPS) | -0.031 |\n| Gross Margin | 10.49% |\n| Net Profit Margin | -0.49% |\n| Debt/Equity Ratio | 458.4% |\nHow did PNL perform over the long term?\nSee historical performance and comparisonDividends\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/24 06:06 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/28 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nPostNL N.V. is covered by 33 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Maarten Bakker | ABN AMRO Bank N.V. |\n| Marco Limite | Barclays |\n| Susanna Invernizzi | Barclays |"
    },
    {
      "url": "https://simplywall.st/company/id/0ba35394-2e5c-478c-b824-85c66b0ca2d5/ownership?utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo&amp;blueprint=4014249",
      "text": "PostNL Ownership\nWho are the major shareholders and have insiders been buying or selling?\nRecent Insider Transactions\nInsider Trading Volume\nInsider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.\nOwnership Breakdown\n| Owner Type | Number of Shares | Ownership Percentage |\n|---|---|---|\n| Institutions | 72,112,265 | 14.2% |\n| Individual Insiders | 178,603,334 | 35.1% |\n| General Public | 257,965,026 | 50.7% |\nDilution of Shares: Shareholders have not been meaningfully diluted in the past year.\nTop Shareholders\n| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |\n|---|---|---|---|---|---|---|\n| 153,093,252 | \u20ac153.4m | 0% | no data | |||\n| 24,803,525 | \u20ac24.9m | 0% | no data | |||\n| 15,041,203 | \u20ac15.1m | 0% | 0.37% | |||\n| 13,304,357 | \u20ac13.3m | -1.37% | no data | |||\n| 9,699,771 | \u20ac9.7m | 239% | no data | |||\n| 9,532,970 | \u20ac9.6m | 0% | no data | |||\n| 7,979,509 | \u20ac8.0m | 0% | 0.51% | |||\n| 4,400,428 | \u20ac4.4m | -16.6% | no data | |||\n| 3,638,211 | \u20ac3.6m | 0% | 0.1% | |||\n| 3,558,149 | \u20ac3.6m | 0% | no data | |||\n| 3,337,675 | \u20ac3.3m | 0.02% | no data | |||\n| 2,644,985 | \u20ac2.7m | 0% | no data | |||\n| 2,277,239 | \u20ac2.3m | 6.61% | no data | |||\n| 2,232,583 | \u20ac2.2m | 0% | 0.31% | |||\n| 1,746,862 | \u20ac1.8m | 0% | 0.18% | |||\n| 1,215,270 | \u20ac1.2m | 0% | no data | |||\n| 1,118,150 | \u20ac1.1m | 0% | 0.6% | |||\n| 901,037 | \u20ac902.8k | 0% | no data | |||\n| 846,979 | \u20ac848.7k | 0% | no data | |||\n| 730,143 | \u20ac731.6k | 0% | no data | |||\n| 583,621 | \u20ac584.8k | 0.19% | no data | |||\n| 486,583 | \u20ac487.6k | 0% | no data | |||\n| 459,235 | \u20ac460.2k | 0% | no data | |||\n| 420,492 | \u20ac421.3k | 0% | 0.01% | |||\n| 314,878 | \u20ac315.5k | 3.23% | no data |\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/24 06:06 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/28 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nPostNL N.V. is covered by 33 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Maarten Bakker | ABN AMRO Bank N.V. |\n| Marco Limite | Barclays |\n| Susanna Invernizzi | Barclays |"
    },
    {
      "url": "https://simplywall.st/company/id/0ba35394-2e5c-478c-b824-85c66b0ca2d5/valuation?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014249",
      "text": "Is PNL undervalued compared to its fair value, analyst forecasts and its price relative to the market?\nValuation Score\n4/6\nValuation Score 4/6\nBelow Fair Value\nSignificantly Below Fair Value\nPrice-To-Sales vs Peers\nPrice-To-Sales vs Industry\nPrice-To-Sales vs Fair Ratio\nAnalyst Forecast\nShare Price vs Fair Value\nWhat is the Fair Price of PNL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.\nDiscounted Cash Flow\nSimply Wall St\n\u20ac1.75\nFair Value\n42.8% undervalued intrinsic discount\n5\nNumber of Analysts\nBelow Fair Value: PNL (\u20ac1) is trading below our estimate of fair value (\u20ac1.75)\nSignificantly Below Fair Value: PNL is trading below fair value by more than 20%.\nKey Valuation Metric\nWhich metric is best to use when looking at relative valuation for PNL?\nKey metric: As PNL is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.\nThe above table shows the Price to Sales ratio for PNL. This is calculated by dividing PNL's market cap by their current\nrevenue.\nWhat is PNL's PS Ratio?\nPS Ratio\n0.2x\nSales\n\u20ac3.28b\nMarket Cap\n\u20ac509.70m\nPNL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.\nPrice-To-Sales vs Industry: PNL is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Logistics industry average (0.8x).\nPrice to Sales Ratio vs Fair Ratio\nWhat is PNL's PS Ratio\ncompared to its\nFair PS Ratio?\nThis is the expected PS Ratio taking into\naccount the company's forecast earnings growth, profit margins\nand other risk factors.\nPNL PS Ratio vs Fair Ratio.\nFair Ratio\nCurrent PS Ratio\n0.2x\nFair PS Ratio\n0.1x\nPrice-To-Sales vs Fair Ratio: PNL is expensive based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.1x).\nAnalyst Price Targets\nWhat is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?\nThe above table shows the analyst PNL forecast and predictions for the stock price in 12 month\u2019s time.\nDate\nShare Price\nAverage 1Y Price Target\nDispersion\nHigh\nLow\n1Y Actual price\nAnalysts\nCurrent\n\u20ac1.00\n\u20ac0.97\n-3.19%\n13.68%\n\u20ac1.20\n\u20ac0.80\nn/a\n5\nAug \u201926\n\u20ac0.93\n\u20ac0.96\n+3.77%\n14.59%\n\u20ac1.20\n\u20ac0.77\nn/a\n5\nJul \u201926\n\u20ac0.95\n\u20ac0.96\n+1.00%\n14.59%\n\u20ac1.20\n\u20ac0.77\nn/a\n5\nJun \u201926\n\u20ac0.96\n\u20ac0.96\n+0.84%\n14.59%\n\u20ac1.20\n\u20ac0.77\nn/a\n5\nMay \u201926\n\u20ac0.90\n\u20ac1.01\n+12.19%\n12.96%\n\u20ac1.20\n\u20ac0.84\nn/a\n5\nApr \u201926\n\u20ac0.99\n\u20ac0.98\n-1.50%\n14.16%\n\u20ac1.20\n\u20ac0.82\nn/a\n6\nMar \u201926\n\u20ac1.01\n\u20ac0.98\n-3.01%\n14.16%\n\u20ac1.20\n\u20ac0.82\nn/a\n6\nFeb \u201926\n\u20ac0.98\n\u20ac1.06\n+8.01%\n16.41%\n\u20ac1.40\n\u20ac0.84\nn/a\n7\nJan \u201926\n\u20ac1.04\n\u20ac1.10\n+5.57%\n14.19%\n\u20ac1.40\n\u20ac0.90\nn/a\n8\nDec \u201925\n\u20ac1.04\n\u20ac1.10\n+6.28%\n14.19%\n\u20ac1.40\n\u20ac0.90\nn/a\n8\nNov \u201925\n\u20ac1.10\n\u20ac1.17\n+6.44%\n10.68%\n\u20ac1.40\n\u20ac1.00\nn/a\n8\nOct \u201925\n\u20ac1.24\n\u20ac1.26\n+2.23%\n15.69%\n\u20ac1.65\n\u20ac1.00\nn/a\n8\nSep \u201925\n\u20ac1.24\n\u20ac1.26\n+1.73%\n15.69%\n\u20ac1.65\n\u20ac1.00\nn/a\n8\nAug \u201925\n\u20ac1.34\n\u20ac1.26\n-5.90%\n16.22%\n\u20ac1.65\n\u20ac1.00\n\u20ac0.93\n8\nJul \u201925\n\u20ac1.29\n\u20ac1.29\n+0.19%\n15.26%\n\u20ac1.65\n\u20ac1.00\n\u20ac0.95\n8\nJun \u201925\n\u20ac1.33\n\u20ac1.24\n-6.20%\n11.45%\n\u20ac1.40\n\u20ac1.00\n\u20ac0.96\n8\nMay \u201925\n\u20ac1.27\n\u20ac1.34\n+6.06%\n9.23%\n\u20ac1.50\n\u20ac1.10\n\u20ac0.90\n6\nApr \u201925\n\u20ac1.26\n\u20ac1.34\n+6.31%\n9.23%\n\u20ac1.50\n\u20ac1.10\n\u20ac0.99\n6\nMar \u201925\n\u20ac1.28\n\u20ac1.39\n+8.51%\n9.19%\n\u20ac1.50\n\u20ac1.10\n\u20ac1.01\n7\nFeb \u201925\n\u20ac1.33\n\u20ac1.57\n+17.98%\n12.71%\n\u20ac1.90\n\u20ac1.30\n\u20ac0.98\n7\nJan \u201925\n\u20ac1.41\n\u20ac1.61\n+14.12%\n10.71%\n\u20ac1.90\n\u20ac1.40\n\u20ac1.04\n8\nDec \u201924\n\u20ac1.48\n\u20ac1.74\n+17.62%\n18.83%\n\u20ac2.50\n\u20ac1.40\n\u20ac1.04\n8\nNov \u201924\n\u20ac1.73\n\u20ac1.93\n+11.79%\n15.69%\n\u20ac2.50\n\u20ac1.40\n\u20ac1.10\n8\nOct \u201924\n\u20ac2.02\n\u20ac1.93\n-4.30%\n15.69%\n\u20ac2.50\n\u20ac1.40\n\u20ac1.24\n8\nSep \u201924\n\u20ac2.15\n\u20ac1.88\n-12.59%\n11.47%\n\u20ac2.10\n\u20ac1.40\n\u20ac1.24\n8\nAug \u201924\n\u20ac1.83\n\u20ac1.61\n-12.05%\n12.07%\n\u20ac2.00\n\u20ac1.40\n\u20ac1.34\n7\nAnalystConsensusTarget\nConsensus Narrative from 5 Analysts\n\u20ac0.97\nFair Value\n3.3% overvalued intrinsic discount\n5\nNumber of Analysts\nAnalyst Forecast: Target price is lower than the current share price.\nDiscover undervalued companies\n7D\n1Y\n7D\n1Y\n7D\n1Y\nCompany Analysis and Financial Data Status\nData\nLast Updated (UTC time)\nCompany Analysis\n2025/08/24 23:50\nEnd of Day Share Price\n2025/08/22 00:00\nEarnings\n2025/06/28\nAnnual Earnings\n2024/12/31\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nPostNL N.V. is covered by 33 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day."
    }
  ],
  "argos_summary": "European markets are buoyed by expectations of lower U.S. borrowing costs, prompting investors to seek growth opportunities in fast\u2011growing European companies with strong insider ownership. The article spotlights PostNL N.V., a Dutch postal and logistics firm trading below fair value with projected earnings growth of 65% per year, and Surgical Science Sweden AB, a virtual\u2011reality medical\u2011training company with high gross margins and a 4/6 valuation score. Both companies exhibit robust growth potential but face challenges\u2014PostNL\u2019s revenue growth lags the Dutch market and its debt\u2011to\u2011equity ratio is high, while Surgical Science has experienced volatile share prices and recent earnings misses. Investors are encouraged to consider these firms as potential undervalued picks amid a broader European growth narrative.",
  "argos_id": "NYIRDVDT4"
}